Ex parte BECHER et al. - Page 13






                        Appeal No. 1997-2336                                                                                                                                                                     
                        Application No. 08/256,065                                                                                                                                                               

                                                 glycerol ester of a partially hydrogenated colophonium and                                                                                                      
                                                 dioctyl cyclohexane dissolved in n-heptane, and silicone oil.                                                                                                   

                        This portion of claim 27 was added by amendment filed June 6, 1996 (Paper No. 15) to                                                                                                     

                        replace matter previously canceled.   Appellants indicate at page 2 of that paper, that "[t]he3                                                                                                                       

                        amendment to claim 27 is to insert the Markush group of substances that preclude or                                                                                                      

                        greatly reduce hydrolysis of acetyl salicylic acid."  We find no written description, in the                                                                                             

                        application as filed, of the members of the Markush group of claim 27 as being substances                                                                                                

                        that preclude or greatly reduce hydrolysis of acetyl salicylic acid in the transdermal patch.                                                                                            

                        The individual members of this group are named in the examples but there is no explicit                                                                                                  

                        statement of their function.  We contrast this lack of description of these substances with                                                                                              

                        the explicit statement at page 7 of the specification which states:                                                                                                                      

                                                 For reducing or suppressing the hydrolysis, substances may                                                                                                      
                                                 be added such as acylating agents, preferably acetylating                                                                                                       
                                                 agents, and, in particular, acetic anhydride, . . .                                                                                                             

                        Further, we compare claim 1 of co-assigned U.S. Patent 5,861,170 to Kissel wherein the                                                                                                   

                        members of the Markush group of claim 27 are designated as "solvents" rather than as                                                                                                     

                        hydrolysis suppressing agents.  The members of the Markush group of claim 27 are                                                                                                         



                                    3Similar terminology was initially added to claim 27 by amendment filed May 25, 1995 (Paper No.                                                                              
                        7) in response to the first Office action.  In the subsequent final rejection, the examiner rejected the claim                                                                           
                        as directed to subject matter which lacked antecedent basis in the application as filed for the description of                                                                           
                        the Markush group of substances as providing hydrophobic adjustments.  This terminology was canceled                                                                                     
                        from claim 27, as well as the other claims in which it appeared, by amendment filed April 8, 1996. (Paper                                                                                
                        No. 11).  Claim 27 was subsequently amended at the time of the filing of the Appeal Brief to reintroduce the                                                                             
                        noted language. (Paper No. 15). While not explicitly stated in the record, the examiner's initials appear on                                                                             
                        this amendment authorizing entry thereof.  Further, the Examiner's Answer, at page 2, indicates that the                                                                                 
                        copy of the claims attached to the Appeal Brief, which included the cited language, was correct.                                                                                         

                                                                                                      13                                                                                                         







Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007